FUNDING ROUND open until 09/30/2023

all the information here

We aim to finance Phase III clinical trials for brain tumor treatment. Current round is the biggest in Laminar’s history with >5.5 million euros raised.

For more information about this investment opportunity

email inversores@laminarpharma.com.

You can also find the information about the current and active

Crowdfunding for Laminar Pharma at Capital Cell

opened in June 2023.

Company News

Scientific publications